Literature DB >> 20351534

Surfactant replacement therapy in influenza A H1N1.

Fahrija Skokić, Igor Hudić, Nesad Hotić, Belkisa Cŏlić, Mirsada Praso, Dubravka Bacaj.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20351534     DOI： 10.1097/INF.0b013e3181cf2eaa

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  2 in total

1.  Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.

Authors:  Masaya Fukushi; Makoto Yamashita; Tohru Miyoshi-Akiyama; Shuku Kubo; Kenji Yamamoto; Koichiro Kudo
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

2.  Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.

Authors:  Abul Bashar Mir Md Khademul Islam; Md Abdullah-Al-Kamran Khan
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.